Mutual Fund Ownership
Ownership as on: Sun, 10 Nov, 2024

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)55.50
% of AUM4.67%

UTI BSE Low Volatility Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)18.89
% of AUM3.50%

JM Value Fund Growth

4/5
Equity
Amount Invested (Cr.)37.28
% of AUM3.49%

JM Flexicap Fund Growth

4/5
Equity
Amount Invested (Cr.)128.96
% of AUM2.73%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)1.90
% of AUM2.34%

FAQs about Dr Reddys Laboratories share price

Dr Reddys Laboratories is trading at 1281.85 as on Fri Nov 08 2024 10:21:35. This is -0.41% lower as compared to its previous closing price of 1287.15.

The market capitalization of Dr Reddys Laboratories is 107242.20 Cr as on Fri Nov 08 2024 10:21:35.

The average broker rating on Dr Reddys Laboratories is Hold. The breakup of analyst rating is given below -

  • 6 analysts have given a strong buy rating
  • 5 analysts have given a buy rating
  • 11 analysts have given a hold rating
  • 7 analysts have given a sell rating
  • 5 analysts have given a strong sell rating

The 52 wk high for Dr Reddys Laboratories is 1420.20 whereas the 52 wk low is 1057.72

Dr Reddys Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 21.06
  • Sector P/E: 34.07
  • Dividend Yield: 0.62%
  • D/E ratio: 0.16

Dr Reddys Laboratories reported a net profit of 5577.90 Cr in 2024.

Recommended For You
Trending Stocks
2,979.25+89.20(3.09%)
3,186.35+66.40(2.13%)
1,682.50+31.40(1.90%)
2,769.25-74.20 (-2.61%)
147.55-3.35 (-2.22%)
HomeMarketsPremiumInstant LoanMint Shorts